COVID-19 Had Lasting Impacts on Clinical Research

Video

Because study coordinators were unable to travel, research pharmacist Brian Wortz, PharmD, said researchers were forced to adapt quickly and figure out what they could do remotely.

The COVID-19 pandemic had a massive impact on clinical trial research, according to research pharmacist Brian Wortz, PharmD, of Cancer Treatment Centers of America. Trial protocols are constantly evolving, Wortz said, although the pandemic accelerated many changes, including the need for virtual communication.

Because study coordinators were unable to travel, Wortz said researchers were forced to adapt quickly and figure out what they could do remotely. For example, he said they received glasses to wear with cameras embedded in them, which allowed coordinators to see the facility and get a feel for how the research was progressing.

Related Videos
palliative and hospice care/ Image Credits: © David Pereiras - stock.adobe.com
cancer pain management | Image Credits: © Burlingham - stock.adobe.com
multiple myeloma clinical trial daratumumab/ Image Credits: © Dragana Gordic - stock.adobe.com
multiple myeloma clinical trial/Image Credits: © Studio Romantic - stock.adobe.com
3d rendered illustration of lung cancer 3D illustration - Image credit:  appledesign | stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
Mayo Clinic oncology pharmacy
© 2024 MJH Life Sciences

All rights reserved.